Back to search

Belgium· BE-AMP-SAM327415-00

Evicel 50 mg - 90 mg - 800 IU - 1200 IU

A local hemostatics product containing human thrombin, registered in Belgium by Omrix Biopharmaceuticals. The same ATC class is registered in 7 of our 19 countries.

ATC B02BC

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedEvicel 50 mg - 90 mg - 800 IU - 1200 …ATCB02BCREGISTER NO.BE-AMP-SAM327415-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Human thrombin is registered in 7 of 19 countries.

Countries holding a registration under ATC B02BC (local hemostatics), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

Human thrombin · ATC B02BC

7 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Icelandprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Human Thrombin
Manufacturer
Omrix Biopharmaceuticals
Country
Belgium (BE)
ATC code
B02BC
ATC class
Local hemostatics
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    7703085
  • be_apb
    3040433

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Human thrombin in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All human thrombin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/21b76b32-5e66-42d1-bf5e-da525523e71b
GET /v1/drugs/21b76b32-5e66-42d1-bf5e-da525523e71b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for sealant",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Evicel 50 mg - 90 mg - 800 IU - 1200 IU",
  "name_fr": "Evicel 50 mg - 90 mg - 800 IU - 1200 IU",
  "name_nl": "Evicel 50 mg - 90 mg - 800 IU - 1200 IU",
  "amp_code": "SAM327415-00",
  "strengths": null,
  "pack_count": 1,
  "substances": [
    "Human Thrombin",
    "Mannitol",
    "Sodium Acetate",
    "Human Clottable Proteins",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Local Hemostatics",
  "authorisation_numbers": [
    "EU/1/08/473/001"
  ]
}

See everything about human thrombin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.